Video abstract: clinical trial protocol of the LUNAR study
LUNAR: a randomized Phase 2 study of 177Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol) The aim of this study is to assess the efficacy of 177Lu-PNT2002, a novel radiolabelled small molecule that binds with high affinity to prostate-specific membrane antigen, in combination with stereotactic body radiotherapy (SBRT) to all sites of metastasis, […]